Management of the patient with gastroparesis

Journal of Clinical Gastroenterology

Volumn 32, Issue 1, 2001, Pages 11-18

  Rabine, J C ^a   Barnett, J L ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

Cisapride; Domperidone; Gastric pacing; Gastroparesis; Metoclopramide

Indexed keywords

ANTIEMETIC AGENT; BETHANECHOL; CISAPRIDE; DOLASETRON MESILATE; DOMPERIDONE; ERYTHROMYCIN; GRANISETRON; METOCLOPRAMIDE; MUSCARINIC AGENT; ONDANSETRON; PHENOTHIAZINE DERIVATIVE; PROCHLORPERAZINE; PROKINETIC AGENT; PROMETHAZINE; SEROTONIN 3 ANTAGONIST; THIETHYLPERAZINE; TRIMETHOBENZAMIDE;

CLINICAL TRIAL; DIET THERAPY; DRUG EFFICACY; DRUG INDUCED DISEASE; GASTROSTOMY; HUMAN; JEJUNOSTOMY; PACEMAKER; PRIORITY JOURNAL; REVIEW; STOMACH PARESIS;

CLINICAL TRIALS; COMBINED MODALITY THERAPY; GASTROINTESTINAL AGENTS; GASTROPARESIS; GASTROSTOMY; HUMANS; JEJUNOSTOMY;

EID: 0035158768     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200101000-00005     Document Type: Review

References (93)

1. The diagnosis and work-up of the patient with gastroparesis
2. Motor function of the stomach in health and disease
3. Approach to the patient with nausea and vomiting
4. The effect of acute hyperglycemia on gastric emptying in man
5. Serum glucose concentration as a modulator of interdigestive gastric motility
6. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins
7. Gastric emptying of solid and liquid meals in glucose-controlled patients with long term diabetes mellitus type I compared to controls
8. Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients
9. Cisapride: A new class of prokinetic agent
10. Acute and chronic effects of cisapride on gastric and esophageal emptying in insulin dependent diabetes mellitus
11. Motor transit and symptomatic effects of cisapride in patients with upper gut dysmotility
12. Long-term efficacy of cisapride in diabetic gastroparesis
13. Cisapride in the long-term treatment of chronic gastroparesis: A 2-year open-label study
14. Open label study of long-term effectiveness of cisapride in patients with idiopathic gastroparesis
15. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility
16. Cisapride in treatment of Roux-en-Y syndrome
17. Appraisal of medium and long-term treatment of gastroparesis and chronic intestinal dysmotility
18. A comparison of two cohort studies evaluating the safety of cisapride: Prescription-event monitoring and a large phase IV study
19. Studies of the effect of metoclopramide and apomorphine on gastric emptying and secretion in man
20. Gastrointestinal effects of metoclopramide in man: In vitro experiments with human smooth muscle preparations
21. Substituted benzamides: Potential non-dopaminergic antagonists of chemotherapy-induced nausea and emesis
22. Effect of metoclopramide on gastrointestinal motility in man
23. Gastroduodenal motility and synchronization
24. Gastric emptying in patients with diabetes mellitus
25. Metoclopramide stimulation of gastric motility and emptying in diabetic gastroparesis
26. Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis
27. Gastric motor abnormalities in diabetic and post-vagotomy gastroparesis: Effect of metoclopramide and bethanechol
28. Effect of metoclopramide in chronic gastric retention after ulcer surgery
29. Increased incidence of levodopa therapy following metoclopramide use
30. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders
31. Metoclopramide-induced movement disorders
32. Mechanisms for the prokinetic action of domperidone
33. Domperidone in the management of symptoms of diabetic gastroparesis: Efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial (DOM-USA-5 Study Group)
34. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis
35. Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis
36. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic persons with symptoms of gastroparesis
37. Gastrointestinal motor effects of erythromycin in humans
38. Erythromycin contracts rabbit colon myocytes via occupation of motilin receptors
39. Erythromycin: The mechanism of its prokinetic action in the treatment of gastroparesis
40. Improvement of gastric emptying in diabetic gastroparesis by erythromycin
41. Erythromycin accelerates gastric emptying by inducing antral contractions and improved gastroduodenal coordination
42. Gastric emptying response to variable oral erythromycin dosing in diabetic gastroparesis
43. Erythromycin enhances early postoperative contractility of the denervated whole stomach as an esophageal substitute
44. Enhancement of gastric emptying of solids by erythromycin in patients with Roux-en-Y gastrojejunostomy
45. Oral erythromycin improves gastrointestinal motility and transit after subtotal but not total gastrectomy for cancer
46. Erythromycin stimulates gastric emptying after esophagectomy with gastric replacement: A randomized clinical trial
47. Disorders of gastric emptying
48. Gastric emptying response to variable oral erythromycin dosing in diabetic gastroparesis
49. Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis
50. Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: One center's experience
51. Treatment of patients with gastroparesis: A meta-analysis of prokinetics
52. Evaluation of oral cisapride and metoclopramide in diabetic autonomic neuropathy: An eight-week double-blind crossover study
53. Domperidone compared to cisapride in the management of gastroparesis
54. Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis
55. Does combination prokinetic therapy benefit patients with refractory diabetic gastroparesis?
56. Combination therapy of cisapride and domperidone: Its effect on gastrointestinal symptoms and overall health status in patients with gastroparesis
57. Role of PEG/PEJ in enteral feeding. American Society for Gastrointestinal Endoscopy policy statement
58. Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis
59. Jejunostomy tube placement in refractory diabetic gastroparesis: A retrospective review
60. Percutaneous endoscopic gastrostomy and gastrojejunostomy: A critical reappraisal of patient selection, tube function and the feasibility of nutritional support during extended follow-up
61. Gastroparesis and the current use of prokinetic drugs
62. Surgical treatment of late postgastrectomy syndromes
63. Reconstructive gastric surgery
64. Completion gastrectomy for postsurgical gastroparesis syndrome. Preliminary results with 15 patients
65. Roux-Y gastrectomy for chronic gastric atony
66. Completion gastrectomy for refractory gastroparesis following surgery for peptic ulcer disease
67. Safety and long-term durability of completion gastrectomy in 81 patients with postsurgical gastroparesis syndrome
68. Surgical therapy of diabetic gastroparesis
69. Radical surgical approach now indicated
70. Gastroparesis cured by gastrectomy
71. Treatment of diabetic gastroparesis with oral clonidine
72. Comparison between the effects of neostigmine and ranitidine on interdigestive gastroduodenal motility of patients with gastroparesis
73. Influence of oral cimetidine and ranitidine on gastric emptying in active duodenal ulcer
74. Dose-related stimulatory effect of clarithromycin in interdigestive gastroduodenal motility
75. Clarithromycin accelerates gastric emptying by inducing powerful antral contractions
76. Botulinum toxin for the treatment of gastroparesis
77. Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis
78. Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: Studies with the CCK antagonist loxiglumide
79. Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis
80. Effect of treatment with Liu-Jun-Zi-Tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients
81. Effect of stimulation of the P6 antiemetic point on postoperative nausea and vomiting
82. Acute effects of acustimulation at Neiguan point on nausea and gastric myoelectric activity in patients with chronic nausea
83. Electro-acupuncture accelerates gastric emptying and increases vagal activity
84. Gastric pacing improves emptying and symptoms in patients with gastroparesis
85. Long-term results of gastric stimulation four times higher than the slow wave frequency in patients with drug refractory gastroparesis
86. Gastric electrical stimulation improves both G1 symptoms and gastric emptying in patients with "postsurgical" gastroparesis
87. Gastric electrical stimulation for gastroparesis: A multi-center double blind cross-over study, by the WAVESS study group
88. Effects of pacing parameters on entrainment of gastric slow waves in patients with gastroparesis
89. Normalization of atropine-induced postprandial dysrhythmias with gastric pacing
90. Effects of gastric pacing on canine gastric motility and emptying
91. Effects of high-frequency gastric stimulation on gastric slow waves, gastric emptying, and symptoms in patients with gastroparesis
92. The influence of gastric electrical stimulation on proximal gastric motor and sensory function in severe idiopathic gastroparesis
93. Microprocessor-controlled movement of solid gastric content using sequential neural electrical stimulation